Sumatriptan Succinate Tablets
SOL #: SPE2D223R0003Solicitation
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Place of performance not available
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Nov 21, 2022
2
Last Updated
Jul 3, 2025
3
Submission Deadline
Jan 20, 2023, 8:00 PM
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Amemdment 0001 issued December 15, 2022 to incorporate statement, DOD Class Deviation 2023-O0001, Verification of Eligibility of Small Business Joint Ventures, into solicitation.
SPE2D2-23-R-0003 SUMATRIPTAN SUCCINATE TABLET SOLICITATION
People
Points of Contact
Phyllis DaraioPRIMARY
Files
Files
No files attached to this opportunity
Versions
Version 9
Award Notice
Posted: Jul 3, 2025
Version 8
Award Notice
Posted: May 16, 2024
Version 7
Award Notice
Posted: Aug 24, 2023
Version 6
Award Notice
Posted: Jul 25, 2023
Version 5
Solicitation
Posted: Feb 3, 2023
Version 4
Solicitation
Posted: Jan 4, 2023
Version 3Viewing
Solicitation
Posted: Dec 15, 2022
Version 2
Solicitation
Posted: Dec 14, 2022
Version 1
Pre-Solicitation
Posted: Nov 21, 2022